 
        
						Berardi Rossana
	
					    												Medical Oncology Unit, Università Politecnica delle Marche – Azienda Ospedaliero-Universitaria,Ospedali Riuniti Umberto I–    GM Lancisi – G Salesi di Ancona, 
ViaConca 71 - 60126Ancona
Italy						                            
                            
						
 Research Article
												Thymic Malignancies in the Targeted Therapies Era 						
Author(s): Berardi Rossana, De Lisa Mariagrazia, Pagliaretta Silvia, Paolucci Vittorio, Morgese Francesca, Savini Agnese, Caramanti Miriam, Ballatore Zelmira, Onofri Azzurra and Cascinu StefanoBerardi Rossana, De Lisa Mariagrazia, Pagliaretta Silvia, Paolucci Vittorio, Morgese Francesca, Savini Agnese, Caramanti Miriam, Ballatore Zelmira, Onofri Azzurra and Cascinu Stefano             
						
												
				 Objective: In the last years, significant efforts have been made in order to improve the knowledge of molecular biology of thymic malignancies. The purpose of this manuscript is to review the recent advances in the treatment of refractory, recurrent thymomas and thymic carcinomas, focusing on molecular targeted therapy and on the previous or actually ongoing clinical trials and genomic analysis. Methods: Available literature on the topic of thymic malignancies was extensively reviewed, using the MEDLINE, CancerLit and ClinicalTrial.gov databases. We searched for targeted therapies studies between restricting our search to English-language publications, including the following search terms: “targeted therapy, octreotide, molecular alterations and pathways” in association with thymoma, thymic carcinoma and thymic neoplasms/ malignancies. Results: Recent thymic malignancies&r.. View More»
				  
												DOI:
												 10.4172/2157-2518.S8-008